beta-Thromboglobulin and platelet factor 4 levels in a case of acute thrombotic thrombocytopenic purpura.
We have described a case of acute thrombotic thrombocytopenic purpura in which multiple therapeutic methods eventuated in recovery. We suggest that the ratio of the platelet marker proteins beta-thromboglobulin and platelet factor 4 may have value in the assessment of therapy and prognosis in following the clinical course of this disorder of platelets.